West Pharmaceutical Services, Inc. (WST)
272.54
+5.58
(+2.09%)
USD |
NYSE |
Dec 11, 16:00
272.54
0.00 (0.00%)
After-Hours: 20:00
West Pharmaceutical Services Research and Development Expense (Quarterly): 17.10M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 514.00M |
| Envista Holdings Corp. | 28.30M |
| Intuitive Surgical, Inc. | 329.40M |
| Becton, Dickinson & Co. | 322.00M |
| ResMed, Inc. | 87.32M |